UK Vision Strategy consultation deadline

Article

The UK Vision Strategy consultation is due to close on 16 November 2012.

The UK Vision Strategy consultation is due to close on 16 November 2012.

Led by VISION 2020, the UK Vision Strategy is the chance to share views and ideas on the future direction of the initiative, as well as the Royal National Institute of Blind People (RNIB).

Anita Lightstone, UK Vision Strategy Programme Director and Interim Chief Operating Officer of VISION 2020 UK, commented, "It is vital that we obtain a wide cross section of views from the sector to help shape the strategy and ensure that we are moving in the right direction. This is a great opportunity for healthcare practitioners, support services, and those living with sight loss to have their say and advise us on how we can best meet their changing needs.''

Please click here for more information on how to participate in the UK Vision Strategy Consultation. Additionally, to share your ideas with the RNIB Group please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.